YELCINO Trademark

Trademark Overview


On Thursday, May 8, 2025, a trademark application was filed for YELCINO with the United States Patent and Trademark Office. The USPTO has given the YELCINO trademark a serial number of 99175227. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, December 10, 2025. This trademark is owned by Sanofi Pasteur. The YELCINO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment and prevention of immune system related diseases and disorders; pharmaceutical products for the treatment and prevention of respiratory diseases and disorders; pharmaceutical products in the nature of anti-inflammatories; pharmaceutical products in the nature of antibodies for medical purposes; vaccines; pharmaceutical products in the nature of therapeutic antibodies for human use for the treatment and prevention of immune system related diseases and disorders; pharmaceutical products in the nature of therapeutic antibodies for human use for the treatment and prevention of respiratory diseases and disorders; vaccines for human use
yelcino

General Information


Serial Number99175227
Word MarkYELCINO
Filing DateThursday, May 8, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, December 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 30, 2025

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment and prevention of immune system related diseases and disorders; pharmaceutical products for the treatment and prevention of respiratory diseases and disorders; pharmaceutical products in the nature of anti-inflammatories; pharmaceutical products in the nature of antibodies for medical purposes; vaccines; pharmaceutical products in the nature of therapeutic antibodies for human use for the treatment and prevention of immune system related diseases and disorders; pharmaceutical products in the nature of therapeutic antibodies for human use for the treatment and prevention of respiratory diseases and disorders; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 8, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi Pasteur
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Trademark Events


Event DateEvent Description
Thursday, May 8, 2025NEW APPLICATION ENTERED
Thursday, May 8, 2025APPLICATION FILING RECEIPT MAILED
Monday, June 2, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, June 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, August 4, 2025ASSIGNED TO EXAMINER
Wednesday, August 13, 2025NON-FINAL ACTION WRITTEN
Wednesday, August 13, 2025NON-FINAL ACTION E-MAILED
Wednesday, August 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 12, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 12, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 12, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 4, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, December 4, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, December 4, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 4, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, December 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 24, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED